Overview

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine: - Whether olanzapine plus fluoxetine in combination will help patients with treatment-resistant major depression. - The safety of olanzapine plus fluoxetine in combination, plus and any side effects that might be associated with the combination. - The effectiveness of olanzapine plus fluoxetine compared to olanzapine and fluoxetine alone.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Fluoxetine
Olanzapine